Curative Biotechnology Stock Analysis
CUBT Stock | USD 0.01 0 8.70% |
Curative Biotechnology is overvalued with Real Value of 0.009576 and Hype Value of 0.01. The main objective of Curative Biotechnology stock analysis is to determine its intrinsic value, which is an estimate of what Curative Biotechnology is worth, separate from its market price. There are two main types of Curative Biotechnology's stock analysis: fundamental analysis and technical analysis.
The Curative Biotechnology stock is traded in the USA on NYSE MKT Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Curative Biotechnology is usually not traded on Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, National Mourning Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day. Curative Stock trading window is adjusted to America/New York timezone.
Curative |
Curative Stock Analysis Notes
The company recorded a loss per share of 0.01. Curative Biotechnology had not issued any dividends in recent years. The entity had 1:400 split on the 2nd of December 2022. Curative Biotechnology, Inc. operates as a development-stage biomedical company. Curative Biotechnology, Inc. was founded in 1995 and is headquartered in Boca Raton, Florida. Curative Biotechnology operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 4 people. For more info on Curative Biotechnology please contact JD Esq at 561 907 8990 or go to https://curativebiotech.com.Curative Biotechnology Investment Alerts
Curative Biotechnology is way too risky over 90 days horizon | |
Curative Biotechnology has some characteristics of a very speculative penny stock | |
Curative Biotechnology appears to be risky and price may revert if volatility continues | |
Curative Biotechnology has high likelihood to experience some financial distress in the next 2 years | |
Curative Biotechnology currently holds 2.26 M in liabilities with Debt to Equity (D/E) ratio of 6.6, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Curative Biotechnology has a current ratio of 0.1, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Curative Biotechnology's use of debt, we should always consider it together with its cash and equity. | |
The entity reported the previous year's revenue of 132.32 K. Net Loss for the year was (3.96 M) with profit before overhead, payroll, taxes, and interest of 100.21 K. | |
Curative Biotechnology currently holds about 126.85 K in cash with (486.58 K) of positive cash flow from operations. |
Curative Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 11.29 M.Technical Drivers
As of the 7th of February, Curative Biotechnology shows the Risk Adjusted Performance of 0.1004, downside deviation of 14.7, and Mean Deviation of 10.41. Curative Biotechnology technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.Curative Biotechnology Price Movement Analysis
The output start index for this execution was thirty-five with a total number of output elements of twenty-six. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Curative Biotechnology middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Curative Biotechnology. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Curative Biotechnology Predictive Daily Indicators
Curative Biotechnology intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Curative Biotechnology stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Daily Balance Of Power | 9.2 T | |||
Rate Of Daily Change | 1.09 | |||
Day Median Price | 0.0125 | |||
Day Typical Price | 0.0125 | |||
Price Action Indicator | 5.0E-4 | |||
Period Momentum Indicator | 0.001 |
Curative Biotechnology Forecast Models
Curative Biotechnology's time-series forecasting models are one of many Curative Biotechnology's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Curative Biotechnology's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Curative Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Curative Biotechnology prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Curative shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Curative Biotechnology. By using and applying Curative Stock analysis, traders can create a robust methodology for identifying Curative entry and exit points for their positions.
Curative Biotechnology, Inc. operates as a development-stage biomedical company. Curative Biotechnology, Inc. was founded in 1995 and is headquartered in Boca Raton, Florida. Curative Biotechnology operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 4 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Curative Biotechnology to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Equity Forecasting Now
Equity ForecastingUse basic forecasting models to generate price predictions and determine price momentum |
All Next | Launch Module |
Additional Tools for Curative Stock Analysis
When running Curative Biotechnology's price analysis, check to measure Curative Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Curative Biotechnology is operating at the current time. Most of Curative Biotechnology's value examination focuses on studying past and present price action to predict the probability of Curative Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Curative Biotechnology's price. Additionally, you may evaluate how the addition of Curative Biotechnology to your portfolios can decrease your overall portfolio volatility.